# VACSERA starts operating new Egivac vaccine plant in Egypt

The Holding Company for Biological Products and Vaccines (VACSERA) started operating a new plant for sera and sterile filling at its subsidiary Egivac, built with investments of EGP 700 million. The plant has a capacity of 8.64 million ampoules and 4.32 million vials per month, producing 13 types of sera and vaccines.

- Type: New facility
- Announced: 2017-08-15
- Where: Egypt, Egypt
- Starts operating: 15 Aug 2017
- Status: completed
- Capacity: 8.64 million ampoules and 4.32 million vials per month
- Products: sera, vaccines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [VACSERA](https://endata.com/companies/26297.md)
- [Egivac](https://endata.com/companies/26298.md) (partner)

## Sources

- [alborsaanews.com](https://alborsaanews.com/2017/08/16/1045099), 2017-08-16: "بدأت الشركة القابضة للأمصال واللقاحات «فاكسيرا»، أمس الثلاثاء، تشغيل مصنع جديد للأمصال والتعبئة العقيمة بالشركة المصرية لإنتاج الأمصال واللقاحات والأدوية«إيجيفاك» بعد إنشاؤه وتجهيزه باستثمارات 700 مليون جنيه."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.